ASIA vs CURE vs DRUG vs MVB
ASIA, CURE, DRUG and MVB hold 260 companies between them. None is in every one of them, and CURE and DRUG are the most alike: 10% of each is the same companies.
Side by side
FundBetaSharesGlobal XBetaSharesVanEck
Asset classSector & thematicSector & thematicSector & thematicSector & thematic
Fee a year0.67%0.45%0.57%0.28%
Fund size$1.2b$39.6m$163.0m$279.0m
Holdings55157668
1Y price return+43.5%+31.1%+6.6%−5.0%
Distribution yield1.79%0.00%3.91%4.53%
Look-through coverage99.8%100.0%99.7%100.0%
Return, last year
change since the start
share of each fund
- ASIA
- CURE
- DRUG
- MVB
- ANZ ANZ GROUP HOLDINGS LIMITEDIn 1 of 4ASIAnot heldCUREnot heldDRUGnot heldMVB20.7%
- NAB NATIONAL AUSTRALIA BANK LIMITEDIn 1 of 4ASIAnot heldCUREnot heldDRUGnot heldMVB20.2%
- WBC WESTPAC BANKING CORPORATIONIn 1 of 4ASIAnot heldCUREnot heldDRUGnot heldMVB20.2%
- CBA COMMONWEALTH BANK OF AUSTRALIA.In 1 of 4ASIAnot heldCUREnot heldDRUGnot heldMVB19.2%
- MQG MACQUARIE GROUP LIMITEDIn 1 of 4ASIAnot heldCUREnot heldDRUGnot heldMVB17.5%
and 250 more companies the funds hold